WellPoint Would Take A Mulligan On Antihistamine Petition In Hindsight
This article was originally published in The Tan Sheet
Executive Summary
If it could do it all over again, WellPoint Health Networks Chief Pharmacy Officer Robert Seidman said the insurer would use an alternate approach to requesting forced over-the-counter switches of certain classes of drugs through a FDA citizen petition
You may also be interested in...
Antihistamine Price Erosion Justifies Forced Switch – WellPoint
WellPoint Health Networks is continuing its campaign to urge a forced Rx-to-OTC switch of low-and non-sedating antihistamines cetirizine, fexofenadine and desloratadine
Antihistamine Price Erosion Justifies Forced Switch – WellPoint
WellPoint Health Networks is continuing its campaign to urge a forced Rx-to-OTC switch of low-and non-sedating antihistamines cetirizine, fexofenadine and desloratadine
Antihistamine Price Erosion Justifies Forced Switch – WellPoint
WellPoint Health Networks is continuing its campaign to urge a forced Rx-to-OTC switch of low-and non-sedating antihistamines cetirizine, fexofenadine and desloratadine